Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-Derived Biocellular Regenerative Therapy in Osteoarthritis
NCT04238143Recruiting
- Sponsor
- Healeon Medical
- Start
- Jan 2020
- Primary completion
- Sep 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous adipose stromal vascular fraction in osteoarthritis (OA) (3 arms), sponsored by Healeon Medical. Primary endpoints: Participant with Complications at 6 months, Numeric Pain Rating Scale at 6 months and 2 more. Started Jan 2020; status: recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04238143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238143.